Avoro Capital Advisors LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 135 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$153,573,000
+36.2%
10,300,0000.0%2.40%
+56.5%
Q2 2023$112,785,000
+25.6%
10,300,0000.0%1.53%
+14.9%
Q1 2023$89,816,000
+39.1%
10,300,0000.0%1.33%
+38.0%
Q4 2022$64,581,000
+79.1%
10,300,0000.0%0.96%
+44.9%
Q3 2022$36,050,000
+18.6%
10,300,0000.0%0.67%
+11.0%
Q2 2022$30,385,000
-5.1%
10,300,0000.0%0.60%
+2.6%
Q1 2022$32,033,000
-8.0%
10,300,0000.0%0.58%
-1.3%
Q4 2021$34,814,000
-7.4%
10,300,0000.0%0.59%
+0.3%
Q3 2021$37,595,000
-16.3%
10,300,0000.0%0.59%
-24.3%
Q2 2021$44,908,000
-4.0%
10,300,0000.0%0.78%
-3.3%
Q1 2021$46,762,000
-20.9%
10,300,0000.0%0.81%
-20.6%
Q4 2020$59,122,000
-20.7%
10,300,0000.0%1.02%
-3.9%
Q3 2020$74,572,000
+307.0%
10,300,000
+96.2%
1.06%
+192.5%
Q2 2020$18,323,000
+125.1%
5,250,000
-4.5%
0.36%
+31.6%
Q1 2020$8,140,000
-24.5%
5,500,0000.0%0.28%
-13.2%
Q4 2019$10,780,000
-22.0%
5,500,000
+103.7%
0.32%
-45.1%
Q3 2019$13,824,000
-28.5%
2,700,0000.0%0.58%
-13.6%
Q2 2019$19,332,000
+100.8%
2,700,000
+272.4%
0.67%
+60.6%
Q1 2019$9,628,000
-44.1%
725,000
-43.5%
0.42%
-37.2%
Q2 2018$17,209,0001,282,3740.66%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders